Viewing Study NCT04782895


Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2026-02-06 @ 8:30 AM
Study NCT ID: NCT04782895
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 2021-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Sponsor: Xiamen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Condylomata Acuminata View
Keywords:

Keywords

Keyword Brief Keyword Text View
None human papillomavirus vaccine View
None immunogenicity View